Dramamine 50 mg Chewable Tablet
RxNorm 602223
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 602223 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Dramamine 50 mg Chewable Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Dimenhydrinate 50 mg Chewable Tablet [Dramamine]
(Atom ID: 12357582)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
DimenhyDRINATE 50 mg Chewable Tablet [Dramamine]
(Atom ID: 3739946)
PSNPrescribable
Prescribable Name (PSN):
Dramamine 50 mg Chewable Tablet
(Atom ID: 6365043)
SYPrescribable
Synonym (SY):
Dramamine 50 mg Chewable Tablet
(Atom ID: 2380832)
Patient Education
Dimenhydrinate
Dimenhydrinate is used to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. Dimenhydrinate is in a class of medications called antihistamines. It works by preventing problems with body balance.
[Learn More]
* Please review the disclaimer below.